Springer Health+ IME: Podcast to Practice

Join Enrique Grande and Maria Lapuente as they explore patient-centered and multidisciplinary approaches to treatment decision-making, patient education, and adverse event management for newer bladder cancer therapies.

‘Raising the Bar in Bladder Cancer Care’ is a three-part podcast series featuring leading experts who discuss the evolving treatment landscape in bladder cancer. Through evidence-based discussions and practical insights, the series explores treatment sequencing in advanced urothelial carcinoma, new perioperative approaches in muscle-invasive bladder cancer, and the importance of multidisciplinary strategies to optimize patient care and adverse event management.

This educational activity is supported by an independent medical education grant from Astellas, and is intended for an audience of healthcare professionals, excluding those based in the US

© 2026 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.

Join Enrique Grande and Michiel van der Heijden as they review the latest evidence supporting perioperative treatment strategies in MIBC, before exploring how evolving biomarkers such as ctDNA and utDNA may help guide risk assessment, treatment selection, and future bladder-preservation strategies.

‘Raising the Bar in Bladder Cancer Care’ is a three-part podcast series featuring leading experts who discuss the evolving treatment landscape in bladder cancer. Through evidence-based discussions and practical insights, the series explores treatment sequencing in advanced urothelial carcinoma, new perioperative approaches in muscle-invasive bladder cancer, and the importance of multidisciplinary strategies to optimize patient care and adverse event management.

This educational activity is supported by an independent medical education grant from Astellas, and is intended for an audience of healthcare professionals, excluding those based in the US

© 2026 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.

Join Enrique Grande and María T Bourlon as they discuss guideline-recommended treatment selection and sequencing in advanced urothelial carcinoma, before exploring the evolving role of biomarkers and how newer therapies are redefining treatment success.

‘Raising the Bar in Bladder Cancer Care’ is a three-part podcast series featuring leading experts who discuss the evolving treatment landscape in bladder cancer. Through evidence-based discussions and practical insights, the series explores treatment sequencing in advanced urothelial carcinoma, new perioperative approaches in muscle-invasive bladder cancer, and the importance of multidisciplinary strategies to optimize patient care and adverse event management.

This educational activity is supported by an independent medical education grant from Astellas, and is intended for an audience of healthcare professionals, excluding those based in the US

© 2026 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.

In episode 3 Enriqueta Felip and Egbert Smit look at the future directions in HER2-positive NSCLC; ongoing clinical trials, emerging novel agents in development, and the role of HER2-targeted therapies in first-line management, with expert perspectives on what lies ahead.

The funding for this educational program is supported by a grant from Daiichi Sankyo Europe (DSE) and AstraZeneca (AZ). DSE and AZ had no involvement in the design, agenda, selection of speakers and participants. This is intended for healthcare professionals. © 2026 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.

In episode 2 Enriqueta Felip and David Planchard cover the practical considerations for implementing HER2-targeted therapies in the treatment of HER2-positive NSCLC, including their integration into treatment pathways, patient selection, monitoring and managing toxicities, and the role of multidisciplinary collaboration.

The funding for this educational program is supported by a grant from Daiichi Sankyo Europe (DSE) and AstraZeneca (AZ). DSE and AZ had no involvement in the design, agenda, selection of speakers and participants. This is intended for healthcare professionals. © 2026 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.

In episode 1 Enriquta Felip and Fernando Lopez-Rios will explore HER2 biomarker testing in NSCLC, looking at current guidelines, distinguishing between HER2 alterations, and practical steps for testing amid real-world barriers.

The funding for this educational program is supported by a grant from Daiichi Sankyo Europe (DSE) and AstraZeneca (AZ). DSE and AZ had no involvement in the design, agenda, selection of speakers and participants. This is intended for healthcare professionals. © 2026 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.

Join Dr. Kristen Flint and Michelle in this compelling patient-physician conversation. Together, they discuss Michelle’s healthcare journey, the day-to-day realities of living with type 2 diabetes, real-world perspectives on CGM (continuous glucose monitoring), and the value shared decision-making.

Earn free CME credits – watch the full accredited video, explore the other accredited activities and download clinical resources on the program website at bit.ly/CGM-Roadmap-Patient-Pod

You can review the full ACCME accreditation statements, learning objectives, and faculty financial disclosures, using this same link.

Intended for healthcare professionals only.

In the final episode of this series “Navigating the conversation: Setting expectations for PC-IOLs", Dr. Jennifer Loh and Dr. Caroline Watson discuss the importance of patient communication, including managing outcome and financial expectations, in presbyopia-correcting intraocular lens (PC-IOL) surgery.

Earn free CME credits – watch the full accredited video podcast series, explore the other accredited activities and download clinical resources on the program website at https://bit.ly/PCIOL-POD4. You can review the full ACCME accreditation statements, learning objectives, and faculty financial disclosures, using this same link.

Intended for healthcare professionals only.

Supported by an independent educational grant from Johnson & Johnson Surgical Vision, Inc. and Alcon Vision, LLC.

© 2026 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.

In the penultimate episode of this series "Mapping the surgical journey", Dr. Jennifer Loh and Dr. Caroline Watson explore a stepwise workflow of presbyopia-correcting intraocular lens (PC-IOL) surgery and IOL formula optimization including individualized calculations and mathematical approaches.

Earn free CME credits – watch the full accredited video podcast series, explore the other accredited activities and download clinical resources on the program website at https://bit.ly/PCIOL-POD3. You can review the full ACCME accreditation statements, learning objectives, and faculty financial disclosures, using this same link.

Intended for healthcare professionals only.

Supported by an independent educational grant from Johnson & Johnson Surgical Vision, Inc. and Alcon Vision, LLC.

© 2026 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.

In the second episode of this series "Diagnostics that drive decisions", Dr. Jennifer Loh and Dr. Rahul Tonk walk through presbyopia-correcting intraocular lens (PC-IOL) preoperative diagnostics and discuss the landscape of PC-IOL technologies.

Earn free CME credits – watch the full accredited video podcast series, explore the other accredited activities and download clinical resources on the program website at https://bit.ly/PCIOL-POD2. You can review the full ACCME accreditation statements, learning objectives, and faculty financial disclosures, using this same link.

Intended for healthcare professionals only.

Supported by an independent educational grant from Johnson & Johnson Surgical Vision, Inc. and Alcon Vision, LLC.

© 2026 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.